A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), Leonardo Ferreira, Ph.D., is taking on type 1 diabetes (T1D) with support ...
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the ...
Dr. Leonardo Ferreira is a recipient of a Breakthrough T1D grant award. In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold ...
A team of researchers has made a breakthrough in diabetes treatment, uncovering a way to regenerate human insulin-producing ...
Biomea Fusion, Inc. has presented promising clinical results for icovamenib, a novel therapy aimed at restoring beta-cell function in patients with type 2 diabetes, at the ATTD 2025 Conference.